Development of a novel fusion inhibitor against T-20-resistant HIV-1.
Oishi
Shinya
S
Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.
Ito
Saori
S
Nishikawa
Hiroki
H
Tanaka
Michinori
M
Ohno
Hiroaki
H
Otaka
Akira
A
Izumi
Kazuki
K
Kodama
Eiichi
E
Matsuoka
Masao
M
Fujii
Nobutaka
N
D000595:Amino Acid Sequence; D002942:Circular Dichroism; D015195:Drug Design; D024882:Drug Resistance, Viral; D000077560:Enfuvirtide; D015700:HIV Envelope Protein gp41 / Q000494:pharmacology*; D023581:HIV Fusion Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D015497:HIV-1 / Q000187:drug effects*; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000494:pharmacology*; D017386:Sequence Homology, Amino Acid
D015700:HIV Envelope Protein gp41; D023581:HIV Fusion Inhibitors; D010446:Peptide Fragments; D000077560:Enfuvirtide